Skip to main content
OpenTrials
Completed

NCT Number: NCT06559202

Inguinal and Axillary LN Size Distribution

Recently, intralymphatic allergen-specific immunotherapy (ILIT) showed promising treatment outcomes for allergic rhinoconjunctivitis. However, the normal size distribution of superficial lymph nodes (LNs) on the trunk that are potential target LNs for ILIT has not been evaluated.

The objective of this study is to investigate the distribution of LN size in inguinal and axillary area.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lymph Nodes

Sex eligibility

All sexes

Study type

Observational

Primary location

Gachon University Gil Medical Center

Incheon, 21565, South Korea

About this study

In this study, the long-axis diameters of the largest LNs in the inguinal and axillary areas were retrospectively measured in subjects who underwent chest and abdominopelvic computed tomography on the same day for health screening purposes from September 2022 to November 2022.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • subjects who underwent chest and abdominopelvic computed tomography on the same day for health screening purposes

Exclusion criteria

  • Malignancy
  • Follow-up less than 1-year

Treatment and study plan

chest and abdominoplevic CT

Diagnostic Test

chest and abdominopelvic computed tomography on the same day for health screening purposes

Primary outcomes

  1. Inguinal LN size

    Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022

    The long-axis diameter of the largest inguinal lymph node

  2. Axillary LN size

    Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022

    The long-axis diameter of the largest axillary lymph node

Secondary outcomes

  1. Subjects with inguinal LN size ≥ 10mm

    Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022

    The number of subjects in whom the long-axis diameter of the largest inguinal lymph node is 10 mm or more.

  2. Subjects with axillary LN size ≥ 10mm

    Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022

    The number of subjects in whom the long-axis diameter of the largest axillary lymph node is 10 mm or more.

Other outcomes

  1. Correlation between inguinal and axillary LN sizes

    Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022

    Correlation between the long-axis diameter of the largest LNs in inguinal area and those in axillary area

  2. Correlation between inguinal LN size and age

    Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022

    Correlation between the long-axis diameter of the largest inguinal LN and age

  3. Correlation between axillary LN size and age

    Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022

    Correlation between the long-axis diameter of the largest axillary LN and age

  4. Correlation between inguinal LN size and height

    Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022

    Correlation between the long-axis diameter of the largest inguinal LN and height

  5. Correlation between axillary LN size and height

    Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022

    Correlation between the long-axis diameter of the largest axillary LN and height

  6. Correlation between inguinal LN size and BMI

    Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022

    Correlation between the long-axis diameter of the largest inguinal LN and BMI

  7. Correlation between axillary LN size and BMI

    Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022

    Correlation between the long-axis diameter of the largest axillary LN and BMI

  8. Correlation between inguinal LN size and weight

    Time frame: On the day when chest and abdominopelvic CT was performed during the study period from 1st SEP 2022 to 30th NOV 2022

    Correlation between the long-axis diameter of the largest inguinal LN and weight

  9. Correlation between axillary LN size and weight

    Time frame: On the day when chest and abdominopelvic CT was during the study period from 1st SEP 2022 to 30th NOV 2022

    Correlation between the long-axis diameter of the largest axillary LN and weight

Sponsors and collaborators

Lead sponsor

Gachon University Gil Medical Center

Other

Collaborators

  • Dankook University

Registry information

Official study title

Evaluation of Inguinal and Axillary Lymph Node Size Distribution for Safe Intralymphatic Injection

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Aug 19, 2024
Registry last updated
Aug 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.